MedPath

The effect of chest wall hyperthermia on the blood oxygen saturation of Covid-19 patients

Phase 2
Conditions
Covid-19 Pneumonia.
covid-19, virus identified
U07.1
Registration Number
IRCT20201122049463N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Positive nasopharyngeal or oropharyngeal PCR test
No sign of underlying disease such as auto immunity disorders
No sign of diabetes
No sign of lung cancer
SPO2 ( 85%-90%) , with out using external oxygen sources.

Exclusion Criteria

Patient's age > 75
SAO2 decrease 48 hours after local hyperthermia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood oxygen saturation. Timepoint: 1 hour before start the study, 1 hour after start the study, 1 times per 6 hours. Method of measurement: Oxygen saturaion system.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath